Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responsesYufeng Xie, J Xiang, Shahid Ahmed et al.|Cancer Gene Therapy|2013Cited by 17
Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic miceY Chen, J Xiang, Yufeng Xie et al.|Cancer Gene Therapy|2011Cited by 13